Combination of substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for use in treating a hematological malignancy

RS68054B1Active Publication Date: 2026-05-29CELGENE CORP

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: RS68054P0
Authority / Receiving Office: RS · RS
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2020-10-20
Filing Date: 2020-10-20
Publication Date: 2026-05-29
Estimated Expiration: 2040-10-20

Application Information

Patent Timeline

20 Oct 2020

Priority

20 Oct 2020

Application

RS68054P0

29 May 2026

Publication

RS68054B1

IPC: A61K31/4045; A61K31/4184; A61K31/436; A61K31/4468; A61K31/47; A61K31/506; A61K31/519; A61K31/52; A61K31/5377; A61K31/55; A61K31/551; A61K31/635; A61K31/675; A61K31/706; A61K31/7076; A61P35/00

CPC: A61K31/5377; A61K45/06; A61P35/00; A61P35/02; A61K31/47; A61K31/4045; A61K31/635; A61K31/519

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.